B2M and neoplasm: We next tested the association of primary/metastasis-specific downregulation of an MHC class I metagene signature composed of a composite expression of HLA-A, HLA-B, HLA-C, B2M, TAP1, TAP2 and NLRC5 between metastasis and matched primary tumor according to intrinsic subtype.